Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients with Hypertension (EPOCH)

Trial Profile

Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients with Hypertension (EPOCH)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2016

At a glance

  • Drugs Eplerenone (Primary) ; ACE inhibitors
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms EPOCH
  • Most Recent Events

    • 19 Apr 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01832558).
    • 12 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top